These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9342718)

  • 1. A staged protocol for the treatment of persistent pulmonary hypertension of the newborn.
    Sasse S; Kribs A; Vierzig A; Roth B
    Klin Padiatr; 1997; 209(5):301-7. PubMed ID: 9342718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of high-frequency flow interruption ventilation and hyperventilation in persistent pulmonary hypertension of the newborn.
    Jirapaet KS; Kiatchuskul P; Kolatat T; Srisuparb P
    Respir Care; 2001 Jun; 46(6):586-94. PubMed ID: 11353547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome.
    Kennaugh JM; Kinsella JP; Abman SH; Hernandez JA; Moreland SG; Rosenberg AA
    J Perinatol; 1997; 17(5):366-9. PubMed ID: 9373841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic chorioamnionitis: an occult marker of severe pulmonary hypertension in the term newborn.
    Woldesenbet M; Perlman JM
    J Perinatol; 2005 Mar; 25(3):189-92. PubMed ID: 15592427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure.
    Carter JM; Gerstmann DR; Clark RH; Snyder G; Cornish JD; Null DM; deLemos RA
    Pediatrics; 1990 Feb; 85(2):159-64. PubMed ID: 2296503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
    Reynolds EW; Ellington JG; Vranicar M; Bada HS
    Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal pulmonary hypertension treated with inhaled nitric oxide and high-frequency ventilation.
    Coates EW; Klinepeter ME; O'Shea TM
    J Perinatol; 2008 Oct; 28(10):675-9. PubMed ID: 18580880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of extracorporeal membrane oxygenators in persistent pulmonary hypertension of the newborn.
    Andrews AF; Roloff DW; Bartlett RH
    Clin Perinatol; 1984 Oct; 11(3):729-35. PubMed ID: 6488675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation in the newborn and beyond.
    Stork E
    Clin Perinatol; 1988 Dec; 15(4):815-29. PubMed ID: 3061700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent pulmonary hypertension of the newborn with transposition of the great arteries.
    Roofthooft MT; Bergman KA; Waterbolk TW; Ebels T; Bartelds B; Berger RM
    Ann Thorac Surg; 2007 Apr; 83(4):1446-50. PubMed ID: 17383355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
    Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
    Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation.
    Walsh-Sukys MC; Cornell DJ; Houston LN; Keszler M; Kanto WP
    Pediatrics; 1994 Sep; 94(3):303-6. PubMed ID: 8065854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure.
    Sills JH; Cvetnic WG; Pietz J
    J Perinatol; 1989 Mar; 9(1):43-8. PubMed ID: 2651595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
    Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
    J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
    Chotigeat U; Khorana M; Kanjanapatakul W
    J Med Assoc Thai; 2002 Jul; 85(7):800-7. PubMed ID: 12296412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy.
    Fakioglu H; Totapally BR; Torbati D; Raszynski A; Sussmane JB; Wolfsdorf J
    J Crit Care; 2005 Sep; 20(3):288-93. PubMed ID: 16253800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic principles relevant for therapeutic procedures in persistent pulmonary hypertension of the newborn.
    Stopfkuchen H
    Klin Padiatr; 1995; 207(2):63-7. PubMed ID: 7752602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.
    Dworetz AR; Moya FR; Sabo B; Gladstone I; Gross I
    Pediatrics; 1989 Jul; 84(1):1-6. PubMed ID: 2740158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn.
    Kumar P; Kazzi NJ; Shankaran S
    Am J Perinatol; 1996 Aug; 13(6):335-41. PubMed ID: 8865978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.